Sera Prognostics

PreTRM™ is a leading brand that offers an innovative and non-invasive blood test for predicting the risk of premature (preterm) birth in pregnancies. This revolutionary PreTRM® Premature Birth Risk Blood Test, developed by Sera Prognostics, provides healthcare providers and expectant mothers with valuable insights to better manage and mitigate the risk of preterm birth. Unlike traditional methods, the PreTRM® Test is clinically validated and commercially available, providing early and individual risk assessments for spontaneous preterm birth, even in asymptomatic, singleton pregnancies.

By identifying more pregnancies at higher risk, this test empowers physicians and mothers to make informed decisions and customize treatment plans, ultimately leading to healthier outcomes for both mother and baby. Whether you're a healthcare provider, a mom-to-be, or a payer or employer, partnering with PreTRM™ means taking proactive steps towards addressing the challenges of preterm birth. With this groundbreaking test, we can work together to improve the long-term health and well-being of babies and families alike, ensuring each day in the womb counts towards a brighter future